Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
about
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsMicroRNAs targeting prostate cancer stem cellsDerivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cellsEvaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial CellsRegulated splicing of the α6 integrin cytoplasmic domain determines the fate of breast cancer stem cells.BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells.Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.Vimentin DNA methylation predicts survival in breast cancerABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.MicroRNA-200 family modulation in distinct breast cancer phenotypes.Towards elucidating the connection between epithelial-mesenchymal transitions and stemnessDynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models.Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells.In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsRole of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cellsSelective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftmentCancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.Role of the microenvironment in ovarian cancer stem cell maintenance.Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporterShort-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burdenGeneration of human epidermis-derived mesenchymal stem cell-like pluripotent cells (hEMSCPCs)miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors.Breast cancer stem cells.Slug promoted vasculogenic mimicry in hepatocellular carcinoma.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype.TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.WNT signaling in glioblastoma and therapeutic opportunities.Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.Positive Quantitative Relationship between EMT and Contact-Initiated Sliding on Fiber-like Tracks.Microelectrode bioimpedance analysis distinguishes basal and claudin-low subtypes of triple negative breast cancer cells.
P2860
Q26748850-796DF4D1-BAED-490F-8099-FBB102B52C57Q28081039-E6FA8BD9-0C37-4C53-B47E-7F0DD21179ECQ28482309-1BB73029-51FF-446B-A735-B766A273F930Q28546316-212D7F6E-4F4C-4AA6-A902-D174E31B37F5Q33685020-BA482027-83E8-4BDB-8EC1-EDC9B0A7E2E8Q33779129-39233A62-C3EE-4640-A21D-FD6439EB0760Q33869770-6195AC68-21AB-4995-996B-54E3BD4C1BBDQ34034767-A390FD2F-9020-49CD-BCA1-99F1D863F13FQ34252280-C3C8B32E-A716-4C72-A512-311B6B305A41Q34288822-C5F49386-B98C-4000-BAAC-AE2F4729D447Q34442318-EED53916-8E58-4B03-84E7-518BCFD0332AQ34462262-2E99D8A9-65F2-4784-8B39-908735D39EC1Q34470537-4BE8D70E-012C-4D3B-9CC9-DA6CE5EA4321Q34672166-D4BB1605-0DDC-46F2-B158-DF76B5BA1A9DQ35017138-53DF93D1-CADD-437C-AD27-951B517DC427Q35037638-14FD7BFD-D4E4-43B5-9C76-7CA3D7005C50Q35425337-8386AF51-2338-4411-A2C7-0397078FC1E7Q35551849-508FAD5D-AF2F-4EEA-A40C-29D6BF214FA6Q36031339-18FC825A-27EA-4D32-BB0E-560DA581C968Q36434358-E7EB6ECD-86A5-4A29-938D-19B3D486A5DAQ36544839-57127F44-B98F-49BB-AD3D-CA1D22F85955Q36618624-3815DF1F-1F09-4682-875A-9B4F1AD5B807Q36645085-4B273DAB-9D99-4A2B-912B-31C990392DB4Q36665179-AAEA2159-B6CC-4A9D-AE9B-C6A1F03483DEQ36772053-7EE465F0-D2C8-472E-8FCD-1B58F02CC88DQ36891437-17ED9C2D-5BE7-43C9-B68D-0AA9E49A4884Q36898895-2200A13A-6E43-4209-B8A8-86EC63E86F44Q36902949-4A6731C2-88B7-424F-8AC8-AD2D172D924CQ36985597-F8CC7C5B-032B-453F-A279-EDA4760A06ACQ37086275-BC728293-A44C-4BC0-B054-5EDBA1093A84Q37121784-364212C6-6A34-455B-95B3-CF7CB942FA07Q37191031-F2E70451-51B0-422A-9261-BA98C465BB9DQ37533025-B20AF3FD-D369-413E-A4C2-7CA7384887E8Q37690555-3DC549B5-70E1-474E-8BAA-E8171CEEBD7FQ37702375-59901EA6-C055-4361-9944-D61944DD6C23Q38319509-4C73E0F5-B12F-4C98-9823-7DB520F90686Q38660744-56F88C05-6F7D-47B6-9EDF-F5FA6A484F7AQ38704813-E7FFF1E5-DE2A-4266-9B99-005B6C186C95Q38742408-E15697A2-76E9-48B2-B646-992A91FC9349Q38848773-AE6E66F4-260C-4FDA-AAE9-550B5146E4D4
P2860
Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Epithelial and mesenchymal sub ...... em cell/progenitor properties.
@en
Epithelial and mesenchymal sub ...... em cell/progenitor properties.
@nl
type
label
Epithelial and mesenchymal sub ...... em cell/progenitor properties.
@en
Epithelial and mesenchymal sub ...... em cell/progenitor properties.
@nl
prefLabel
Epithelial and mesenchymal sub ...... em cell/progenitor properties.
@en
Epithelial and mesenchymal sub ...... em cell/progenitor properties.
@nl
P2093
P2860
P356
P1433
P1476
Epithelial and mesenchymal sub ...... em cell/progenitor properties.
@en
P2093
Alan Mackay
Chris K Franklin
Clare M Isacke
David Sarrio
P2860
P304
P356
10.1002/STEM.791
P577
2012-02-01T00:00:00Z